$2.02
-$0.04
(-1.94%)
Quote as of 4:00 PM EST on 02/09/12
Arena Pharmaceuticals, Inc.
NASDAQ:ARNA
|
$2.02
-$0.04
(-1.94%)
|
|
| Today's Open | $2.05 |
|---|---|
| Previous Close | $2.06 |
| Daily Range | $2.01 - $2.06 |
| 52-Week Range | $1.21 - $2.62 |
| Market Cap | $294.97M |
| P/E Ratio | -2.37 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 1,922,189 |
| Average Daily Volume | 3,611,877 |
| Current FY EPS | -$0.78 |
ARNA Information
| Description |
|---|
| A clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. |
| Sector |
| Healthcare |
| Industry |
| Biotechnology |
News & Commentary
Amgen, Vivus, Chelsea Therapeutics Prep for Key Catalysts in February
The Simple Strategy That Beat the Market
Zacks #1 Rank Additions for Thursday - Tale of the Tape
6 Key Drivers for Biotechnology's 2012 Outlook
Zacks #1 Rank Additions for Monday - Tale of the Tape
Zacks #1 Rank Additions for Tuesday - Tale of the Tape
Diet Pill Scorecard: Vivus, Arena, Orexigen Still Chasing Market Approvals
Zacks #1 Rank Additions for Wednesday - Tale of the Tape
US Stock Futures: HOT STOCKS TO WATCH
Has Arena Pharmaceuticals Become the Perfect Stock?
